# The Benefits of Long-read High-throughput Genomic Sequencing for the Causal Diagnosis of Cerebellar Ataxias

> **NCT06467175** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 210 (estimated)

## Conditions studied

- Cerebellar Ataxias

## Interventions

- **BIOLOGICAL:** blood sampling for high molecular weight DNA extraction

## Key facts

- **NCT ID:** NCT06467175
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-11
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06467175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06467175, "The Benefits of Long-read High-throughput Genomic Sequencing for the Causal Diagnosis of Cerebellar Ataxias". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06467175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*